Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection
Adam J. Gehring, Patricia Méndez, Kirsten Richter, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 525-538
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The scientific basis of combination therapy for chronic hepatitis B functional cure
Seng Gee Lim, Thomas F. Baumert, Carolina Boni, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 4, pp. 238-253
Open Access | Times Cited: 93
New Perspectives on Development of Curative Strategies for Chronic Hepatitis B
Jordan J. Feld, Anna S. Lok, Fabien Zoulim
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2040-2050
Open Access | Times Cited: 30
Toward a Functional Cure for Hepatitis B
Anna S. Lok
Gut and Liver (2024) Vol. 18, Iss. 4, pp. 593-601
Open Access | Times Cited: 13
Review Article: Assessing the virological response to direct-acting antiviral therapies in the HBV cure programme.
James Lok, James Michael Harris, Ivana Carey, et al.
Virology (2025) Vol. 605, pp. 110458-110458
Closed Access | Times Cited: 1
Hepatitis B functional cure and immune response
Jia-Rui Zheng, Zilong Wang, Bo Feng
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies
Hui Ma, Qing-Zhu Yan, Jingru Ma, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1295-1312
Open Access | Times Cited: 8
Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies
Georgia Zeng, Apostolos Koffas, Lung‐Yi Mak, et al.
JHEP Reports (2023) Vol. 5, Iss. 6, pp. 100720-100720
Open Access | Times Cited: 12
Combining therapeutic agents to target the immune systems of hepatitis B patients: what do we need to consider?
Shang‐Chin Huang, Jia‐Horng Kao
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-5
Closed Access
Recent Insights into the Role of B Cells in Chronic Hepatitis B and C Infections
Zgjim Osmani, André Boonstra
Pathogens (2023) Vol. 12, Iss. 6, pp. 815-815
Open Access | Times Cited: 7
Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates
Samuel Kim, Jeffrey J. Wallin, Yanal Ghosheh, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100817-100817
Open Access | Times Cited: 7
The immune response in chronic HBV infection
Antonio Bertoletti
Journal of Viral Hepatitis (2024)
Open Access | Times Cited: 2
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes
Marion G. Peters, Man‐Fung Yuen, Norah A. Terrault, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 983-990
Open Access | Times Cited: 6
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B
Conan Chua, Loghman Salimzadeh, Ann T., et al.
Hepatology Communications (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 6
Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations
Dwaipayan Mukherjee, Michelle A. Collins, Douglas E. Dylla, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 8, pp. 2057-2070
Open Access | Times Cited: 4
Major open questions in the hepatitis B and D field – Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop
Thomas Tu, Jochen M. Wettengel, Yuchen Xia, et al.
Virology (2024) Vol. 595, pp. 110089-110089
Closed Access | Times Cited: 1
Polyethylene imine-modified photonic crystal microfluidic chip for highly sensitive detection of microbial spores
Wang Peng, Yuankai Zhang, Chao Yi, et al.
Food Chemistry (2024) Vol. 459, pp. 140366-140366
Closed Access | Times Cited: 1
HBV biomarkers and their role in guiding treatment decisions
Lung‐Yi Mak, Tobias Boettler, Upkar S. Gill
Seminars in Liver Disease (2024) Vol. 44, Iss. 04, pp. 474-491
Closed Access | Times Cited: 1
Quest for immunological biomarkers in the management of CHB patients
Antonio Bertoletti, Nina Le Bert
Gut (2023) Vol. 72, Iss. 11, pp. 2012-2014
Closed Access | Times Cited: 3
Assessing the chronic hepatitis B adaptive immune response by profiling specific T-cell receptor repertoire
Xueying Li, Anqi Zheng, Jiabang Liu, et al.
Antiviral Research (2023) Vol. 214, pp. 105608-105608
Closed Access | Times Cited: 3
Hepatocyte proliferation favours viral clearance in young children with chronic hepatitis B virus infection
Limin Wang, Shuhong Liu, Chunya Wang, et al.
Acta Paediatrica (2022) Vol. 112, Iss. 2, pp. 305-310
Closed Access | Times Cited: 3
Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, R Ono, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2402-2417
Open Access
Exploration of 1-(indolin-1-yl)-2-(thiazol-2-yl)ethan-1-one derivatives as novel anti-HBV agent with potential TLR7-agonistic effect
Shuqiong Li, Lihua Yang, Qiuting Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116575-116575
Closed Access
High-throughput and specific detection of microorganisms by intelligent modular fluorescent photoelectric microbe detector
Qian Cui, Shanqun Gan, Yongjie Zhong, et al.
Analytica Chimica Acta (2023) Vol. 1265, pp. 341282-341282
Closed Access | Times Cited: 1
Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
Thomas Tu, Harout Ajoyan, Jacob George
Clinics in Liver Disease (2023) Vol. 27, Iss. 4, pp. 837-855
Closed Access | Times Cited: 1
Current challenges in the functional cure of HBe-antigen negative chronic hepatitis B
Henar Calvo Sánchez, Julia Peña‐Asensio, J.R. Larrubia
Revista Española de Enfermedades Digestivas (2022) Vol. 114
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top